Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-12-04
2009-06-30
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388220, C530S388250, C424S130100, C424S133100, C424S135100, C424S143100, C435S410000
Reexamination Certificate
active
07553936
ABSTRACT:
The present invention relates to methods and compositions for modulating platelet activity, and methods and compositions for treating a disease or disorder associated with platelet activity in a subject, comprising administering a single chain anti-TREM-like transcript-1 (TLT-1) antibody or a functional fragment or variant thereof in an amount effective to modulate platelet activity.
REFERENCES:
patent: 2004/0180409 (2004-09-01), McVicar et al.
patent: WO 02/06329 (2002-01-01), None
Bird et al., Science 1988, 242:423-426.
Giomarelli Barbara
McVicar Daniel W.
Mori Toshiyuki
Washington A. Valance
Corless Peter F.
Edwards Angell Palmer & & Dodge LLP
Gambel Phillip
Sparks Jonathan M.
The United States of America as represented by Secretary Departm
LandOfFree
Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4148395